Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases

Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases

US Patent 10774126 · Granted Sep 15, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Molecules that selectively activate regulatory T cells for the treatment of auto2022
Method for treating disease using FOXP3+CD4+ T cells2022
IL-2 variants for the treatment of psoriasis2021
Multivalent regulatory T cell modulators2021
Molecules that selectively activate regulatory T cells for the treatment of auto2020
Nucleic acid encoding human IL-2 variant2020
Multivalent regulatory T cell modulators2019
Molecules that selectively activate regulatory T cells for the treatment of auto2019
Modified IL-2 variants that selectively activate regulatory T cells2018
PEGylated aspartyl-tRNA synthetase polypeptides2017
Aspartyl-tRNA synthetases2017
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases2016